Atossa Genetics changes name to Atossa Therapeutics
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook
Infographic: The Big Picture 2023 Sustainability Outlook
Atossa Genetics Inc., a Seattle-based biopharmaceutical company, changed its name to Atossa Therapeutics Inc.
The company said the name change more clearly reflects its focus on developing therapies for breast cancer, breast density and other breast conditions.
Atossa's common stock will continue to trade on the NasdaqCM exchange under the ATOS symbol.
